UW Medical Center - Northwest is a 281-bed hospital in Seattle, Washington. It was built in 1960 and became part of the UW Medicine system in 2010. Prior to the merger, a 1997 agreement had already made Northwest the home for a UW Medicine cardiac surgery program.

There are 281 beds in University of Washington Medical Center - Northwest.

During the past decade, University of Washington Medical Center - Northwest conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 27 clinical trials were completed, i.e. on average, 245.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 14 clinical trials were completed. i.e. 350% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Washington Medical Center - Northwest" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "Gynecologic Oncology Group" with 8 trials sponsored, "University of Washington" with 8 trials sponsored, "GOG Foundation" with 4 trials sponsored and "Frederick Schmitt" with 4 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Washington Medical Center - Northwest" #1 collaborator was "NRG Oncology" with 13 trials as a collaborator, "National Cancer Institute (NCI)" with 13 trials as a collaborator, "National Institute on Aging (NIA)" with 3 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "University of Washington Medical Center - Northwest" are "Recurrent Fallopian Tube Carcinoma" (9 trials), "Recurrent Ovarian Carcinoma" (9 trials), "Recurrent Primary Peritoneal Carcinoma" (9 trials), "Endometrial Clear Cell Adenocarcinoma" (8 trials) and "Endometrial Serous Adenocarcinoma" (8 trials). Many other conditions were trialed in "University of Washington Medical Center - Northwest" in a lesser frequency.

Most popular intervention types in "University of Washington Medical Center - Northwest" are "Drug" (24 trials), "Other" (24 trials), "Biological" (10 trials), "Behavioral" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Paclitaxel" (16 trials), "Quality-of-Life Assessment" (11 trials), "Carboplatin" (10 trials) and "Questionnaire Administration" (6 trials). Other intervention names were less common.

The vast majority of trials in "University of Washington Medical Center - Northwest" are 27 trials for "Female" genders, 8 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Washington Medical Center - Northwest". undefined are not yet recruiting, 2 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in University of Washington Medical Center - Northwest, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Washington Medical Center - Northwest, 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".